Skip to Content
Merck
CN
  • Mutation screening of the ubiquitin ligase gene RNF135 in French patients with autism.

Mutation screening of the ubiquitin ligase gene RNF135 in French patients with autism.

Psychiatric genetics (2015-09-15)
Julie Tastet, Loïc Decalonne, Sylviane Marouillat, Joëlle Malvy, Rose-Anne Thépault, Annick Toutain, Agathe Paubel, Refaat Tabagh, Hélène Bénédetti, Frédéric Laumonnier, Catherine Barthélémy, Frédérique Bonnet-Brilhault, Christian R Andres, Patrick Vourc'h
ABSTRACT

Many genes are now thought to confer susceptibility to autism. Despite the fact that this neuropsychiatric disease appears to be related to several different causes, common cellular and molecular pathways have emerged and point to synaptic dysfunction or cellular growth. Several studies have indicated the importance of the ubiquitin pathway in synaptic function and the aetiology of autism. Here, we focused on the ring finger protein 135 (RNF135) gene, encoding an E3 ubiquitin ligase expressed in the cortex and cerebellum, and located in the NF1 gene locus in 17q11.2, a region linked to autism. We carried out a genetic analysis of the coding sequence of RFN135 in a French cohort of patients with autism and observed a significantly increased frequency of genotypes carrying the rare allele of the rs111902263 (p.R115K) missense variant in patients (P=0.0019, odds ratio: 4.23, 95% confidence interval: 1.87-9.57). Particularly, three unrelated patients showed a homozygous genotype for K115, a situation not observed in the 1812 control individuals. Further cellular and molecular studies are required to elucidate the role of this gene and the variant K115 in brain development and neuronal function.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
1,3-Propanediol, 98%